1. Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer. Issue 12 (1st December 2020) Authors: Pack, Christopher D.; Bommireddy, Ramireddy; Munoz, Luis E.; Patel, Jaina M.; Bozeman, Erica N.; Dey, Paulami; Radhakrishnan, Vijayaraghavan; Vartabedian, Vincent F.; Venkat, Kalpana; Ramachandiran, Sampath; Reddy, Shaker J. C.; Selvaraj, Periasamy Journal: Human vaccines & immunotherapeutics Issue: Volume 16:Issue 12(2020) Page Start: 3184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗